Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and Hypotheses
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.00515
Abstract: Immunotherapies in tumors have attracted increasing attention. They play an important role in precision medicine. Many immune-checkpoint inhibitors (ICIs) have obtained FDA approval and show good performance in the clinic. Hyperprogressive disease (HPD) after ICIs… read more here.
Keywords: immune checkpoint; treatment characteristics; inhibitor treatment; hyperprogression immune ... See more keywords